These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 6639836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH, Back DJ, Breckenridge AM, Howells RE.
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR, Egan JM, Dickinson TH, Carrum G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [Abstract] [Full Text] [Related]

  • 6. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
    Staiger C, Schlicht F, Walter E, Gundert-Remy U, Hildebrandt R, de Vries J, Wang NS, Harenberg J, Weber E.
    Eur J Clin Pharmacol; 1983 Mar; 25(6):797-801. PubMed ID: 6141054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M, Verbeek RM, van Boxtel CJ, Boeijinga JK, Breimer DD.
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F, Almar M, Pozuelo M, Sansegundo D, González-Sastre M, González-Gallego J.
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M, Krom DP, Breimer DD.
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V, Desager JP, Horsmans Y, Van Nieuwenhuyze Y, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [Abstract] [Full Text] [Related]

  • 15. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG, Bayon JE, González-Gallego J.
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [Abstract] [Full Text] [Related]

  • 16. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW, van der Veen EA, Doodeman PJ, Breimer DD.
    Eur J Clin Pharmacol; 1984 Sep; 27(1):99-103. PubMed ID: 6489432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
    Anadón A, Martinez-Larrañaga MR, Fernandez MC, Diaz MJ, Bringas P.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.